Morgan Stanley »

Cognition Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.0k 3.0k 1.66
2024-03-31 $5.5k 3.0k 1.82
2023-12-31 $41k 22k 1.85
2023-09-30 $32k 22k 1.44
2023-06-30 $40k 22k 1.83
2022-12-31 $46k 22k 2.10
2022-06-30 $46k 22k 2.10